Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
OTC Markets EXMKT - Delayed Quote USD

Sorrento Therapeutics, Inc. (SRNE)

Compare
0.0010
0.0000
(0.00%)
At close: April 1 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
64,270
62,839
52,904
39,986
Cost of Revenue
35,629
33,452
13,031
9,940
Gross Profit
28,641
29,387
39,873
30,046
Operating Expense
384,162
407,888
407,918
231,572
Operating Income
-355,521
-378,501
-368,045
-201,526
Net Non Operating Interest Income Expense
-6,811
-8,574
-10,224
-20,157
Other Income Expense
-190,426
-174,672
-84,259
-88,897
Pretax Income
-552,758
-561,747
-462,528
-310,580
Tax Provision
9,310
-2,416
-33,516
-2,014
Earnings from Equity Interest Net of Tax
-18,735
-18,426
-126
-5,844
Net Income Common Stockholders
-547,998
-572,843
-428,325
-298,461
Average Dilution Earnings
-12,374
--
--
--
Diluted NI Available to Com Stockholders
-547,998
-572,843
-428,325
-298,461
Basic EPS
-1.10
-1.37
-1.45
-1.30
Diluted EPS
-1.10
-1.37
-1.45
-1.30
Basic Average Shares
507,859
419,315
294,774
229,823
Diluted Average Shares
507,859
419,315
294,774
229,823
Total Operating Income as Reported
-462,646
-504,315
-401,451
-244,518
Total Expenses
419,791
441,340
420,949
241,512
Net Income from Continuing & Discontinued Operation
-547,998
-572,843
-428,325
-298,461
Normalized Income
-399,836.6600
-398,189.4067
-376,926.4447
-210,702.7949
Interest Income
--
--
--
24
Interest Expense
6,811
8,574
10,224
20,157
Net Interest Income
-6,811
-8,574
-10,224
-20,157
EBIT
-545,947
-553,173
-452,304
-290,423
EBITDA
-532,020
-539,928
-439,842
-279,416
Reconciled Cost of Revenue
26,212
24,532
4,709
2,986
Reconciled Depreciation
13,927
13,245
12,462
11,007
Net Income from Continuing Operation Net Minority Interest
-547,998
-572,843
-428,325
-298,461
Total Unusual Items Excluding Goodwill
-187,546
-175,408
-55,414
-88,331
Total Unusual Items
-187,546
-175,408
-55,414
-88,331
Normalized EBITDA
-344,474
-364,520
-384,428
-191,085
Tax Rate for Calcs
0.0002
0
0.0001
0
Tax Effect of Unusual Items
-39,384.6600
-754.4067
-4,015.4447
-572.7949
12/31/2020 - 9/13/1999

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VXRT Vaxart, Inc.
0.3725
-8.48%
 
AARD Aardvark Therapeutics, Inc. Common Stock
8.29
+10.39%
 
CELU Celularity Inc.
1.7200
-0.58%
 
THTX Theratechnologies Inc.
1.4000
0.00%
 
LPTX Leap Therapeutics, Inc.
0.2913
-4.52%
 
DRMA Dermata Therapeutics, Inc.
0.9997
-7.44%
 
IBRX ImmunityBio, Inc.
2.9600
-1.66%
 
OCEA Ocean Biomedical, Inc.
0.0549
+1.67%
 
OSRH OSR Holdings, Inc.
1.7200
-8.51%
 
MURA Mural Oncology plc
1.2400
-1.59%